| Measuring primary care exam length using electronic health record data HT Neprash, A Everhart, D McAlpine, LB Smith, B Sheridan, DA Cross Medical care 59 (1), 62-66, 2021 | 35 | 2021 |
| Association between regulatory submission characteristics and recalls of medical devices receiving 510 (k) clearance AO Everhart, S Sen, AD Stern, Y Zhu, P Karaca-Mandic JAMA 329 (2), 144-156, 2023 | 11 | 2023 |
| Physician variation in the de‐adoption of ineffective statin and fibrate therapy A Everhart, NR Desai, B Dowd, J Herrin, L Higuera, MM Jeffery, AB Jena, ... Health services research 56 (5), 919-931, 2021 | 5 | 2021 |
| Using NLP to extract predicate history from medical device approvals Y Zhu, A Everhart, PK Mandic, S Sen | 5 | 2020 |
| Trends in testosterone prescriptions for older men enrolled in commercial insurance and medicare advantage A Everhart, K Harper, MM Jeffery, Z Levin, NE Morden, A Sankar, ... JAMA Network Open 4 (9), e2127349-e2127349, 2021 | 4 | 2021 |
| Patient and provider-level factors associated with changes in utilization of treatments in response to evidence on ineffectiveness or harm LB Smith, NR Desai, B Dowd, A Everhart, J Herrin, L Higuera, MM Jeffery, ... International journal of health economics and management 20, 299-317, 2020 | 4 | 2020 |
| Exploring the validity of developing an interdisciplinarity score of a patient's needs: care coordination, patient complexity, and patient safety indicators A Hodgson, L Etzkorn, A Everhart, N Nooney, J Bestrashniy The Journal for Healthcare Quality (JHQ) 39 (2), 107-121, 2017 | 2 | 2017 |
| Time to publication of cost-effectiveness analyses for medical devices AO Everhart The American journal of managed care 29 (5), 265, 2023 | 1 | 2023 |
| Manufacturer Payments to Physicians: Information, Persuasion, and the Adoption of New Medical Technologies AO Everhart, BE Landon, SLT Normand | 1 | 2022 |
| Late Manufacturer Reports in the Manufacturer and User Facility Device Experience Database A Everhart, P Karaca-Mandic, R Redberg, JS Ross, S Dhruva ASHEcon 2024 Conference, 2024 | | 2024 |
| Longitudinal Patterns in Testosterone Prescribing After US FDA Safety Communication in 2014 A Sankar, AO Everhart, AB Jena, MM Jeffery, JS Ross, ND Shah, ... The Joint Commission Journal on Quality and Patient Safety 49 (9), 458-466, 2023 | | 2023 |
| Regulatory Submission Characteristics and Recalls of Medical Devices Receiving 510 (k) Clearance—Reply AO Everhart, Y Zhu, AD Stern JAMA 329 (18), 1609-1610, 2023 | | 2023 |
| The Persuasive and Informative Roles of Manufacturer Payments to Physicians: Evidence from Leadless Pacemaker Adoption AO Everhart, BE Landon, SLT Normand | | 2023 |
| Manufacturer Payments and the Adoption New Medical Technologies A Everhart, B Landon, SL Normand | | 2022 |
| Manufacturer Payments and the Adoption of Leadless Pacemakers in Fee-for-Service Medicare G Kanter, A Everhart, B Landon, SL Normand ASHEcon 2022 Conference, 2022 | | 2022 |
| Predicate Characteristics and Recalls of 510 (k) Medical Devices A Everhart, S Sen, A Stern, Y Zhu, P Karaca-Mandic 2022 Annual Research Meeting, 2022 | | 2022 |
| Physician Network Connections Associated With Faster De-Adoption of Dronedarone for Permanent Atrial Fibrillation C Stecher, A Everhart, LB Smith, A Jena, JS Ross, NR Desai, N Shah, ... Circulation: Cardiovascular Quality and Outcomes 14 (10), e008040, 2021 | | 2021 |
| Uptake of evidence by physicians: De-adoption of erythropoiesis-stimulating agents after the TREAT trial K Vu, J Zhou, A Everhart, N Desai, J Herrin, AB Jena, JS Ross, ND Shah, ... BMC nephrology 22 (1), 284, 2021 | | 2021 |
| Financial Shocks and Innovation in the Medical Device Industry: Quasi-Experimental Evidence from Hurricanes A Everhart | | 2021 |
| Essays on Innovation in the Medical Device Industry AO Everhart University of Minnesota, 2021 | | 2021 |
Pinar Karaca MandicUniversity of Minnesota and NBERBestätigte E-Mail-Adresse bei umn.edu
